HOUSTON, Oct. 31, 2024 /PRNewswire/ -- In recent years, antibody therapies have seen rapid advancements, becoming pivotal treatments for cancer, infectious diseases, and autoimmune disorders.

Participants with nephrotic syndrome in NEPTUNE Match will receive information about the PIONEER study and other clinical ...

combined groups: −5.4 mV (p < 0.001) CF = cystic fibrosis; FEV 1 = forced expiratory volume in 1 second. The classes of cystic fibrosis transmembrane conductance regulator (CFTR) mutations.

Operator Good afternoon, and welcome to AbCellera's Q3 2024 business update conference call. My name is Tamia, and I will ...

In this article, we take a look at five biotech companies developing potentially transformative medicines to treat cystic ...

This important study advances our understanding of the mechanisms controlling lipid flux and ion permeation in the TMEM16 and OSCA/TMEM63 family channels. The study provides compelling new evidence ...

Nuclear medicine combines structural and functional imaging, thus detecting lesions earlier than traditional methodologies. CD147 is a transmembrane glycoprotein that is expressed at very low levels ...

Odisha government has translocated a tigress from the Tadoba-Andhari Tiger Reserve, Maharashtra, to the Similipal Tiger ...

Ivacaftor was safe and well tolerated but did not improve clinical or cystic fibrosis transmembrane conductance regulator (CFTR)-related outcomes after 12 weeks vs placebo in patients with chronic ...